Balanced news tone
News Sentiment
2561 sentiment intelligence
VISEN Pharmaceuticals news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
71/100 classification confidence.
directly relevant articles
high-authority source matches
-23.3% over one week, +1.0% over four weeks, trend inactive, and below fair value.
AI pullback drives capital into 'safe havens'! Hong Kong-listed innovative drug stocks surge across the board, with VISEN Pharmaceuticals surging nearly 30% on heavy volume.
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
AI pullback drives capital into 'safe havens'! Hong Kong-listed innovative drug stocks surge across the board, with VISEN Pharmaceuticals surging nearly 30% on heavy volume.
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jul 2026 05:46
- Source
- 富途牛牛
VISEN Pharmaceuticals Adds New Director Appointments to AGM Agenda
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Jun 2026 07:00
- Source
- The Globe and Mail
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de
VISEN Pharmaceuticals' (HKG:2561) largest shareholders are public companies who were rewarded as market cap surged HK$412m last week
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jan 2026 08:00
- Source
- simplywall.st